Gaining access to Retatrutide, the new medication for metabolic conditions, currently presents a limitation for many. Currently , it isn't widely available in most areas . Limited clinical studies and a phased rollout are playing a role to this situation. Patients interested in getting Retatrutide should speak with their doctor to evaluate suitabil